ResearcherAccuronix Therapeutics, Inc.No recent work listed

Bradley T. Keller

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on NIH RePORTER profile ID 15907042. Sources: NIH RePORTER.

Their work

Papers: 0
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2022: 1 grant

Grants 1

Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC) R42CA239853 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

William G. Hawkins · 1 shared grant, 2022 · strength 0.66
- Grant Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC) R42CA239853 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.